Prevalence of Esophageal Candidiasis Among Patients Treated With Inhaled Fluticasone Propionate

American Journal of Gastroenterology

Volumn 98, Issue 10, 2003, Pages 2146-2148

  Kanda, Naoki ^b   Yasuba, Hirotaka ^b   Takahashi, Teruko ^b   Mizuhara, Yuka ^b   Yamazaki, Syuji ^b   Imada, Yuko ^b   Izumi, Yoshio ^b   Kobayashi, Yoshiki ^b   Yamashita, Kenzo ^b   Kita, Hideo ^b   Tamada, Takashi ^b   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE;

ADULT; AGED; ARTICLE; ASTHMA; CANDIDIASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; POWDER INHALER; PREVALENCE; PRIORITY JOURNAL;

EID: 0142245795     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07626.x     Document Type: Article

References (15)

1. The Lung Health Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000;343:1902-9.
2. Vestbo J, Sorensen T, Lange P, et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial. Lancet 1999;353:1819-23.
3. Barnes PJ. A new approach to the treatment of asthma. N Engl J Med 1989;321:1517-27.
4. Adams N, Bestall J, Jones PW. Inhaled fluticasone propionate for chronic asthma. Cochrane Database Syst Rev 2001;3: CD003135.
5. Kuna P. Longterm effects of steroid therapy. Wiad Lek 1998;51(suppl 1):12-8.
6. Dubus JC, Marguet C, Deschildre A, et al. Local side-effects of inhaled corticosteroids in asthmatic children: Influence of drug, dose, age, and device. Allergy 2001;56:944-8.
7. Kesten S, Hyland RH, Pruzanski WR, Kortan PP. Esophageal candidiasis associated with beclomethasone dipropionate aerosol therapy. Drug Intell Clin Pharm 1988;22:568-9.
8. Sievert W, Holmes P, King RW. Oesophageal candidosis in patients on high-dose inhaled steroids. Lancet 1992;339:1551-2.
9. Simon MR, Houser WL, Smith KA, Long PM. Esophageal candidiasis as a complication of inhaled corticosteroids. Ann Allergy Asthma Immunol 1997;79:333-8.
10. Andersen LI, Frederiksen HJ, Appleyard M. Prevalence of esophageal Candida colonization in a Danish population: Special reference to esophageal symptoms, benign esophageal disorders, and pulmonary disease. J Infect Dis 1992;165:389-92.
11. Hoshika K, Mine H. Significance of modes of adherence in esophageal Candida albicans. J Gastroenterol 1994;29:1-5.
12. Eras P, Goldstein MJ, Sherlock P. Candida infection of the gastrointestinal tract. Medicine 1972;51:367-79.
13. Lipworth BJ. Clinical pharmacology of corticosteroids in bronchial asthma. Pharmacol Ther 1993;58:173-209.
14. Bartholomew GA, Rodu B, Bell DS. Oral candidiasis in patients with diabetes mellitus: A thorough analysis. Diabetes Care 1987;10:607-12.
15. Dorocka-Bobkowska B, Budtz-Jorgensen E, Wloch S. Non-insulin-dependent diabetes mellitus as a risk factor for denture stomatitis. J Oral Pathol Med 1996;25:411-5.